Table 1.
Clinical characteristics of case group and control group.
| Parameter | Cases (N = 146) | Controls (N = 158) | P |
|---|---|---|---|
| Gender, female (%) | 66 (45.21%) | 77 (48.73%) | 0.538 |
| Age (years) | 40.86 ± 12.32 | 40.00 ± 6.98 | 0.462 |
| WBC(×109/L) | 6.01 ± 1.38 | 6.33 ± 1.51 | 0.052 |
| HB (g/L) | 142.19 ± 14.44 | 137.24 ± 16.47 | 0.006 |
| PLT (×109/L) | 218.53 ± 54.10 | 231.38 ± 52.13 | 0.026 |
| ALT (U/L) | 20.61 ± 10.28 | 20.06 ± 9.22 | 0.624 |
| AST (U/L) | 19.25 ± 5.05 | 18.56 ± 4.66 | 0.217 |
| γ-GT (U/L) | 21.87 ± 19.13 | 20.97 ± 11.88 | 0.62 |
| ALP (U/L) | 69.95 ± 24.82 | 66.92 ± 17.55 | 0.218 |
| TB (μmol/L) | 24.93 ± 9.71 | 11.83 ± 3.04 | <0.001 |
| DB (μmol/L) | 8.95 ± 4.54 | 4.41 ± 1.20 | <0.001 |
| IB (μmol/L) | 15.97 ± 6.82 | 7.46 ± 2.00 | <0.001 |
| TP (g/L) | 76.07 ± 6.73 | 75.54 ± 4.02 | 0.414 |
| ALB (g/L) | 44.98 ± 3.65 | 44.12 ± 2.27 | 0.016 |
| GLB(g/L) | 5.51 ± 3.66 | 6.10 ± 2.66 | 0.121 |
| FPG (mmol/L) | 4.99 ± 0.80 | 4.86 ± 0.51 | 0.106 |
| TC (mmol/L) | 4.40 ± 0.84 | 4.41 ± 0.71 | 0.896 |
| TG (mmol/L) | 1.40 ± 0.78 | 1.53 ± 1.02 | 0.211 |
| HDL (mmol/L) | 1.32 ± 0.29 | 1.27 ± 0.28 | 0.096 |
| LDL (mmol/L) | 2.64 ± 0.69 | 2.65 ± 0.63 | 0.907 |
| BUN (mmol/L) | 4.72 ± 1.03 | 4.85 ± 1.13 | 0.319 |
| CR (mmol/L) | 67.63 ± 11.58 | 67.27 ± 12.39 | 0.803 |
| UA (μmol/L) | 324.59 ± 92.30 | 321.18 ± 87.54 | 0.824 |
P-values were calculated between groups by using t-test for continuous variables and the χ2 test for categorical variables.
WBC, white blood cell count; HB, hemoglobin; PLT, platelet; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GT, glutamyltransferase; ALP, alkaline phosphatase; TB, total bilirubin; DB, direct bilirubin; IB, indirect bilirubin; TP, total protein; ALB, albumin; GLB, globulin; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; BUN, blood urea nitrogen; CR, creatinine; UA, uric acid.